“There will be less invention, investment and innovation in vaccines generally, across all the companies,” Dr. Stephen Hoge, the president of Moderna, said in an interview.
Wait? That's bad?
>“There will be less invention, investment and innovation in vaccines generally, across all the companies,” Dr. Stephen Hoge, the president of Moderna, said in an interview.
Wait? That's bad?